Premium
Venture capital firms Ventureast and Eight Roads Ventures have inked a deal to exit a Bengaluru-based biotechnology firm, striking a multi-bagger in the process even as the long gestation period shrunk their annualised returns. Indian drug maker Laurus Labs Ltd said on Wednesday it has agreed to buy the majority stake ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.